Premium pharmaCann Target cannabis retailers and dispensaries seeking high-end, consistent cannabis experiences; position Albert Einstone’s El Blunto and Stoneade as premium, controlled products with a focus on uniformity to drive repeat purchases and brand loyalty.

California Footprint Leverage existing distribution in nearly 350 California dispensaries to upsell additional SKUs, cross-sell Stoneade beverages to existing cannabis customers, and partner with retailers looking to diversify premium cannabis beverage and cigar categories.

Science Driven Highlight the scientific cultivation and control narrative to win partnerships with retailers and formulators seeking traceable, soil-grown organic profiles; explore co-branding or white-label opportunities focused on transparency and quality metrics.

End-to-End Control Emphasize turnkey collaboration opportunities from cultivation to final product; offer contract manufacturing or private-label arrangements for retailers desiring consistent product experiences and scalable supply.

Growth Readiness With a revenue range of 25–50 million and a lean team, present scale-up capabilities, demand forecasting, and reliable supply to potential distributors or multi-store operators seeking proven premium brands to accelerate expansion.